342 related articles for article (PubMed ID: 38140058)
21. A promising RNA nanotechnology in clinical therapeutics: a future perspective narrative review.
Tolba MM; Jabbar A; Afzal S; Mahmoud M; Zulfiqar F; El-Soudany I; Samir S; Wadan AS; Ellakwa TE; Ellakwa DE
Future Sci OA; 2023 Sep; 9(8):FSO883. PubMed ID: 37621841
[TBL] [Abstract][Full Text] [Related]
22. Status and future directions in the management of pancreatic cancer: potential impact of nanotechnology.
Sielaff CM; Mousa SA
J Cancer Res Clin Oncol; 2018 Jul; 144(7):1205-1217. PubMed ID: 29721665
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive bioinformatics analysis reveals the oncogenic role of FoxM1 and its impact on prognosis, immune microenvironment, and drug sensitivity in osteosarcoma.
Shi S; Wang Q; Du X
J Appl Genet; 2023 Dec; 64(4):779-796. PubMed ID: 37782449
[TBL] [Abstract][Full Text] [Related]
24. Nanotechnology-integrated ovarian cancer metastasis therapy: Insights from the metastatic mechanisms into administration routes and therapy strategies.
Huang Y; Li C; Zhang X; Zhang M; Ma Y; Qin D; Tang S; Fei W; Qin J
Int J Pharm; 2023 Apr; 636():122827. PubMed ID: 36925023
[TBL] [Abstract][Full Text] [Related]
25. Recent developments in nanomaterials for upgrading treatment of orthopedics diseases.
Shang J; Zhou C; Jiang C; Huang X; Liu Z; Zhang H; Zhao J; Liang W; Zeng B
Front Bioeng Biotechnol; 2023; 11():1221365. PubMed ID: 37621999
[TBL] [Abstract][Full Text] [Related]
26. Extracellular Vesicle (EV) biohybrid systems for cancer therapy: Recent advances and future perspectives.
Ou YH; Liang J; Czarny B; Wacker MG; Yu V; Wang JW; Pastorin G
Semin Cancer Biol; 2021 Sep; 74():45-61. PubMed ID: 33609664
[TBL] [Abstract][Full Text] [Related]
27. Evolving gene therapy approaches for osteosarcoma using viral vectors: review.
Witlox MA; Lamfers ML; Wuisman PI; Curiel DT; Siegal GP
Bone; 2007 Apr; 40(4):797-812. PubMed ID: 17189720
[TBL] [Abstract][Full Text] [Related]
28. The Potential of Nano-Based Photodynamic Treatment as a Therapy against Oral Leukoplakia: A Narrative Review.
Angjelova A; Jovanova E; Polizzi A; Santonocito S; Lo Giudice A; Isola G
J Clin Med; 2023 Oct; 12(21):. PubMed ID: 37959284
[TBL] [Abstract][Full Text] [Related]
29. Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughs.
Chen C; Xie L; Ren T; Huang Y; Xu J; Guo W
Cancer Lett; 2021 Mar; 500():1-10. PubMed ID: 33359211
[TBL] [Abstract][Full Text] [Related]
30. Curcumin and its Analogs and Carriers: Potential Therapeutic Strategies for Human Osteosarcoma.
Lu KH; Lu PW; Lu EW; Lin CW; Yang SF
Int J Biol Sci; 2023; 19(4):1241-1265. PubMed ID: 36923933
[TBL] [Abstract][Full Text] [Related]
31. Functionalized Keratin as Nanotechnology-Based Drug Delivery System for the Pharmacological Treatment of Osteosarcoma.
Martella E; Ferroni C; Guerrini A; Ballestri M; Columbaro M; Santi S; Sotgiu G; Serra M; Donati DM; Lucarelli E; Varchi G; Duchi S
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463350
[TBL] [Abstract][Full Text] [Related]
32. Advances in Bone-targeted Drug Delivery Systems for Neoadjuvant Chemotherapy for Osteosarcoma.
Li CJ; Liu XZ; Zhang L; Chen LB; Shi X; Wu SJ; Zhao JN
Orthop Surg; 2016 May; 8(2):105-10. PubMed ID: 27384718
[TBL] [Abstract][Full Text] [Related]
33. Diabetology and Nanotechnology: A Compelling Combination.
Karwasra R; Sharma S; Sharma I; Shahid N; Umar T
Recent Pat Nanotechnol; 2023 Nov; ():. PubMed ID: 37937555
[TBL] [Abstract][Full Text] [Related]
34. Advances in Osteosarcoma.
Panez-Toro I; Muñoz-García J; Vargas-Franco JW; Renodon-Cornière A; Heymann MF; Lézot F; Heymann D
Curr Osteoporos Rep; 2023 Aug; 21(4):330-343. PubMed ID: 37329384
[TBL] [Abstract][Full Text] [Related]
35. Extracellular vesicle-mediated delivery of miR-101 inhibits lung metastasis in osteosarcoma.
Zhang K; Dong C; Chen M; Yang T; Wang X; Gao Y; Wang L; Wen Y; Chen G; Wang X; Yu X; Zhang Y; Wang P; Shang M; Han K; Zhou Y
Theranostics; 2020; 10(1):411-425. PubMed ID: 31903129
[No Abstract] [Full Text] [Related]
36. Challenges and opportunities in metastatic breast cancer treatments: Nano-drug combinations delivered preferentially to metastatic cells may enhance therapeutic response.
Yu J; Mu Q; Fung M; Xu X; Zhu L; Ho RJY
Pharmacol Ther; 2022 Aug; 236():108108. PubMed ID: 34999182
[TBL] [Abstract][Full Text] [Related]
37. Targeted therapy for osteosarcoma: a review.
Li S; Zhang H; Liu J; Shang G
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6785-6797. PubMed ID: 36807762
[TBL] [Abstract][Full Text] [Related]
38. Advanced nanoscale drug delivery systems for bone cancer therapy.
Amiryaghoubi N; Fathi M; Barar J; Omidian H; Omidi Y
Biochim Biophys Acta Mol Basis Dis; 2023 Aug; 1869(6):166739. PubMed ID: 37146918
[TBL] [Abstract][Full Text] [Related]
39. Next-generation nanomaterials: advancing ocular anti-inflammatory drug therapy.
Wei J; Mu J; Tang Y; Qin D; Duan J; Wu A
J Nanobiotechnology; 2023 Aug; 21(1):282. PubMed ID: 37598148
[TBL] [Abstract][Full Text] [Related]
40. Bone-Targeted Dual Functional Lipid-coated Drug Delivery System for Osteosarcoma Therapy.
Zhong J; Wen W; Wang J; Zhang M; Jia Y; Ma X; Su YX; Wang Y; Lan X
Pharm Res; 2023 Jan; 40(1):231-243. PubMed ID: 36380167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
